![]() Number of administered second doses (by percentage of total population):
20-40%
41-60%
61-80%
81-90%
91-100% | |
Date | March 8, 2021 | – present
---|---|
Location | ![]() |
Cause | COVID-19 pandemic in Vietnam |
Target | Immunization against COVID-19 |
Budget | 25.2 trillion VND ($1.1 billion USD)[1][2] |
Organised by | Vietnam's Ministry of Health |
Participants | 90,272,853[3] people with at least one dose administered of COVID-19 vaccine.
85,961,564[3] people have been fully vaccinated. |
Outcome | 91.94[3] percent of the Vietnamese population has received at least one dose.
87.55[3] percent of the Vietnamese population is fully vaccinated. |
Part of a series on the |
COVID-19 pandemic |
---|
![]() |
|
![]() |
The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022.[4] The Sputnik V was later approved for use on 23 March 2021.[5] The Sinopharm BIBP vaccine was approved for emergency use on 4 June 2021,[6] while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021,[7] 29 June 2021,[8][9] and 15 July 2021,[10][11] respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021,[12] and Covaxin from Bharat Biotech on 10 November 2021.[13][14]
This is the country's largest-ever immunization campaign, aiming to administer over 150 million doses.[15] As of 6 April 2022, Vietnam has administered 207,235,119 vaccine doses across the country.[16]
asianikkei0406
was invoked but never defined (see the help page).ldo1507
was invoked but never defined (see the help page).